{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:05:16Z","timestamp":1791378316912,"version":"4.3.2"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008478","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2022-11-00074"],"award-info":[{"award-number":["PICT-2022-11-00074"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2019-00117"],"award-info":[{"award-number":["PICT-2019-00117"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2018-3088"],"award-info":[{"award-number":["PICT-2018-3088"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["MICIU\/AEI \/ 10.13039\/501100011033"],"award-info":[{"award-number":["MICIU\/AEI \/ 10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2021-128283OA-I00"],"award-info":[{"award-number":["PID2021-128283OA-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2022-137265OB-I00"],"award-info":[{"award-number":["PID2022-137265OB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008056","name":"Florencio Fiorini Faoundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008992","name":"International Society for Neurochemistry","doi-asserted-by":"publisher","award":["ISN-CAEN 2023"],"award-info":[{"award-number":["ISN-CAEN 2023"]}],"id":[{"id":"10.13039\/501100008992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017585","name":"National Interuniversitary Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017585","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"National Scientific and Technical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.lfs.2025.123822","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:22:14Z","timestamp":1751023334000},"page":"123822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Targeting FOXP3 in glioblastoma: Blockade of tumor intrinsic effects boosts response to chemo-radiotherapy"],"prefix":"10.1016","volume":"378","author":[{"given":"Mat\u00edas","family":"Garcia Fallit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Pe\u00f1a Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro J.","family":"Nicola Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazareno","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"P\u00e9rez K\u00fcper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamila","family":"Zampini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Clara","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Sobarzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"S\u00e1nchez Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebe","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Perona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisina Bel\u00e9n","family":"Ripari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo A.","family":"Videla-Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia A.","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Casares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Lasarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianela","family":"Candolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supplement_6","key":"10.1016\/j.lfs.2025.123822_bb0005","doi-asserted-by":"crossref","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010351","article-title":"Molecular mechanisms of treatment resistance in glioblastoma","volume":"22","author":"Ou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.lfs.2025.123822_bb0020","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/cmi.2015.10","article-title":"FOXP3+ regulatory T cells and their functional regulation","volume":"12","author":"Li","year":"2015","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123822_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9020197","article-title":"Searching for peptide inhibitors of T regulatory cell activity by targeting specific domains of FOXP3 transcription factor","volume":"9","author":"Lozano","year":"2021","journal-title":"Biomedicines"},{"issue":"42","key":"10.1016\/j.lfs.2025.123822_bb0030","doi-asserted-by":"crossref","first-page":"71709","DOI":"10.18632\/oncotarget.17845","article-title":"Blockage of FOXP3 transcription factor dimerization and FOXP3\/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor","volume":"8","author":"Lozano","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.lfs.2025.123822_bb0035","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.4049\/jimmunol.1001114","article-title":"A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice","volume":"185","author":"Casares","year":"2010","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2025.123822_bb0040","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.21873\/anticanres.13730","article-title":"FOXP3 inhibitory peptide P60 increases efficacy of cytokine-induced killer cells against renal and pancreatic cancer cells","volume":"39","author":"Setiawan","year":"2019","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41401-024-01338-0","article-title":"Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice","volume":"46","author":"Serrano","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2025.123822_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114871","article-title":"Stimulation of antitumor immunity by FoxP3-targeting PROTAC","volume":"163","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.lfs.2025.123822_bb0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10549-017-4414-2","article-title":"Therapeutic blockade of Foxp3 in experimental breast cancer models","volume":"166","author":"Moreno Ayala","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12943-017-0700-1","article-title":"FOXP3 promotes tumor growth and metastasis by activating Wnt\/beta-catenin signaling pathway and EMT in non-small cell lung cancer","volume":"16","author":"Yang","year":"2017","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.lfs.2025.123822_bb0065","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1159\/000479442","article-title":"The role of tumoral FOXP3 on cell proliferation, migration, and invasion in gastric cancer","volume":"42","author":"Zhang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"10","key":"10.1016\/j.lfs.2025.123822_bb0070","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.18632\/oncotarget.644","article-title":"FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration","volume":"3","author":"Frattini","year":"2012","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.lfs.2025.123822_bb0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.yexcr.2012.11.018","article-title":"The transcription factor Forkhead box P3 (FoxP3) is expressed in glioma cells and associated with increased apoptosis","volume":"319","author":"Held-Feindt","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2025.123822_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1479-5876-6-19","article-title":"Foxp3 expression in human cancer cells","volume":"6","author":"Karanikas","year":"2008","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cas.13118","article-title":"Forkhead box P3 regulates ARHGAP15 expression and affects migration of glioma cells through the Rac1 signaling pathway","volume":"108","author":"Sun","year":"2017","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12094-013-1037-x","article-title":"Clinical significance of FOXP3 expression in human gliomas","volume":"16","author":"Wang","year":"2014","journal-title":"Clin. Transl. Oncol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123822_bb0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41419-024-06619-4","article-title":"FOXP3 promote the progression of glioblastoma via inhibiting ferroptosis mediated by linc00857\/miR-1290\/GPX4 axis","volume":"15","author":"Cao","year":"2024","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.lfs.2025.123822_bb0100","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1159\/000485784","article-title":"Calycosin inhibits the migration and invasion of human breast cancer cells by down-regulation of Foxp3 expression","volume":"44","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"27","key":"10.1016\/j.lfs.2025.123822_bb0105","doi-asserted-by":"crossref","first-page":"44694","DOI":"10.18632\/oncotarget.17974","article-title":"FOXP3 inhibits cancer stem cell self-renewal via transcriptional repression of COX2 in colorectal cancer cells","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.lfs.2025.123822_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/v15030608","article-title":"Evaluation of Baculoviruses as gene therapy vectors for brain cancer","volume":"15","author":"Garcia Fallit","year":"2023","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.lfs.2025.123822_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/v15091813","article-title":"Targeting FOXP3 tumor-intrinsic effects using adenoviral vectors in experimental breast cancer","volume":"15","author":"Nicola Candia","year":"2023","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.lfs.2025.123822_bb0120","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0125","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41467-022-28372-y","article-title":"Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target","volume":"13","author":"Abdelfattah","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2025.123822_bb0130","series-title":"Single Cell Portal: An Interactive Home for Single-cell Genomics Data","author":"Tarhan","year":"2023"},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0135","doi-asserted-by":"crossref","first-page":"17729","DOI":"10.1038\/s41598-022-20910-4","article-title":"Noxa and Mcl-1 expression influence the sensitivity to BH3-mimetics that target Bcl-xL in patient-derived glioma stem cells","volume":"12","author":"Vera","year":"2022","journal-title":"Sci. Rep."},{"issue":"479","key":"10.1016\/j.lfs.2025.123822_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaq1427","article-title":"IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response","volume":"11","author":"Nunez","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bpa.12263","article-title":"Specific preferences in lineage choice and phenotypic plasticity of glioma stem cells under BMP4 and noggin influence","volume":"26","author":"Videla Richardson","year":"2016","journal-title":"Brain Pathol."},{"issue":"16","key":"10.1016\/j.lfs.2025.123822_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164061","article-title":"Mitochondrial peptide humanin facilitates chemoresistance in glioblastoma cells","volume":"15","author":"Pena Agudelo","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.lfs.2025.123822_bb0155","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.lfs.2025.123822_bb0165","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.lfs.2025.123822_bb0170","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1101\/gr.135350.111","article-title":"GENCODE: the reference human genome annotation for The ENCODE Project","volume":"22","author":"Harrow","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.lfs.2025.123822_bb0175","series-title":"R: A Language and Environment for Statistical Computing","author":"Team","year":"2010"},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.lfs.2025.123822_bb0185","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.lfs.2025.123822_bb0190","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"issue":"43","key":"10.1016\/j.lfs.2025.123822_bb0195","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.lfs.2025.123822_bb0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cyto.2007.06.004","article-title":"Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library","volume":"39","author":"Dotor","year":"2007","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.lfs.2025.123822_bb0205","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.0022-202X.2005.23859.x","article-title":"Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis","volume":"125","author":"Santiago","year":"2005","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.lfs.2025.123822_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12050421","article-title":"Encapsulating TGF-beta1 inhibitory peptides P17 and P144 as a promising strategy to facilitate their dissolution and to improve their functionalization","volume":"12","author":"Hanafy","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2025.123822_bb0215","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.3389\/fimmu.2019.03136","article-title":"Molecular mechanisms controlling Foxp3 expression in health and autoimmunity: from epigenetic to post-translational regulation","volume":"10","author":"Colamatteo","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2025.123822_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112767","article-title":"TGF-beta-mediated epithelial-mesenchymal transition and cancer metastasis","volume":"20","author":"Hao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2025.123822_bb0225","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/brainsci15060637","article-title":"Integrated workflow for drug repurposing in glioblastoma: computational prediction and preclinical validation of therapeutic candidates","volume":"15","author":"Gonzalez","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.lfs.2025.123822_bb0230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jconrel.2017.03.007","article-title":"Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats","volume":"263","author":"Zhang","year":"2017","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.lfs.2025.123822_bb0235","doi-asserted-by":"crossref","first-page":"10865","DOI":"10.1039\/C4NR03693J","article-title":"Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma","volume":"6","author":"Setua","year":"2014","journal-title":"Nanoscale"},{"issue":"33","key":"10.1016\/j.lfs.2025.123822_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202203958","article-title":"Brain co-delivery of temozolomide and cisplatin for combinatorial glioblastoma chemotherapy","volume":"34","author":"Zou","year":"2022","journal-title":"Adv. Mater."},{"issue":"17","key":"10.1016\/j.lfs.2025.123822_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28176253","article-title":"Graphene oxide enhanced cisplatin cytotoxic effect in glioblastoma and cervical cancer","volume":"28","author":"Kregielewski","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0250","first-page":"34","article-title":"Combination of cisplatin and temozolomide versus carboplatin and etoposide in the treatment of recurrent high grade glioma patients","volume":"30","author":"Elwan","year":"2024","journal-title":"Zagazig University Medical Journal"},{"issue":"21","key":"10.1016\/j.lfs.2025.123822_bb0255","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1158\/1078-0432.CCR-14-1298","article-title":"Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence","volume":"20","author":"de Biasi","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.lfs.2025.123822_bb0260","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"46","key":"10.1016\/j.lfs.2025.123822_bb0265","doi-asserted-by":"crossref","first-page":"20021","DOI":"10.1073\/pnas.1008261107","article-title":"Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics","volume":"107","author":"Candolfi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.lfs.2025.123822_bb0270","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1158\/1078-0432.CCR-09-0155","article-title":"Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity","volume":"15","author":"Candolfi","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2025.123822_bb0275","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.13520","article-title":"Human FOXP3 and tumour microenvironment","volume":"168","author":"Wang","year":"2023","journal-title":"Immunology"},{"issue":"17","key":"10.1016\/j.lfs.2025.123822_bb0280","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1158\/0008-5472.CAN-06-3304","article-title":"Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer","volume":"67","author":"Hinz","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2025.123822_bb0285","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.mce.2014.10.006","article-title":"Inhibition of Foxp3 in cancer cells induces apoptosis of thyroid cancer cells","volume":"399","author":"Chu","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123822_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050038","article-title":"Epigenetic control of the foxp3 locus in regulatory T cells","volume":"5","author":"Floess","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.lfs.2025.123822_bb0295","article-title":"Targeted de-methylation of the FOXP3-TSDR is sufficient to induce physiological FOXP3 expression but not a functional Treg phenotype","volume":"11","author":"Kressler","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123822_bb0300","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1476-4598-13-153","article-title":"Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival","volume":"13","author":"Zhuo","year":"2014","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2025.123822_bb0305","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4049\/jimmunol.1901275","article-title":"Methylation-sensitive restriction enzyme quantitative polymerase chain reaction enables rapid, accurate, and precise detection of methylation status of the regulatory T cell (Treg)-specific demethylation region in primary human Tregs","volume":"206","author":"Perry","year":"2021","journal-title":"J. Immunol."},{"issue":"19","key":"10.1016\/j.lfs.2025.123822_bb0310","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1016\/j.jmb.2019.07.031","article-title":"Recruitment of histone methyltransferase Ehmt1 to Foxp3 TSDR counteracts differentiation of induced regulatory T cells","volume":"431","author":"Karl","year":"2019","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123822_bb0315","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139542","article-title":"Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice","volume":"131","author":"Kadiyala","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2025.123822_bb0320","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11010-015-2377-3","article-title":"Alterations in gene promoter methylation and transcript expression induced by cisplatin in comparison to 5-Azacytidine in HeLa and SiHa cervical cancer cell lines","volume":"404","author":"Sood","year":"2015","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0325","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-022-01614-9","article-title":"Correction: cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2025.123822_bb0330","first-page":"131","article-title":"Combined therapy with cisplatin and 5-AZA-2CdR modifies methylation and expression of DNA repair genes in oral squamous cell carcinoma","volume":"15","author":"Lima","year":"2022","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.lfs.2025.123822_bb0335","first-page":"1655","article-title":"Acute application of cisplatin affects methylation status in neuroblastoma cells","volume":"25","author":"Tabata","year":"2011","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0340","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41398-023-02560-w","article-title":"Irradiation and lithium treatment alter the global DNA methylation pattern and gene expression underlying a shift from gliogenesis towards neurogenesis in human neural progenitors","volume":"13","author":"Neofytou","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0345","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1038\/s41598-023-31828-w","article-title":"Epigenetic modification of gene expression in cancer cells by terahertz demethylation","volume":"13","author":"Cheon","year":"2023","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.lfs.2025.123822_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105654","article-title":"The advances in epigenetics for cancer radiotherapy","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2025.123822_bb0355","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3892\/etm.2016.3092","article-title":"CDKN2B, SLC19A3 and DLEC1 promoter methylation alterations in the bone marrow of patients with acute myeloid leukemia during chemotherapy","volume":"11","author":"Hong","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"10","key":"10.1016\/j.lfs.2025.123822_bb0360","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1600-6143.2004.00566.x","article-title":"TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors","volume":"4","author":"Fu","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.lfs.2025.123822_bb0365","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1084\/jem.20042276","article-title":"TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells","volume":"201","author":"Marie","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.123822_bb0370","first-page":"392","article-title":"FOXP3 expression is modulated by TGF-beta1\/NOTCH1 pathway in human melanoma","volume":"42","author":"Skarmoutsou","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.lfs.2025.123822_bb0375","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1172\/JCI65416","article-title":"TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer","volume":"123","author":"Bhola","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2025.123822_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104745","article-title":"TGF-beta in radiotherapy: mechanisms of tumor resistance and normal tissues injury","volume":"155","author":"Farhood","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.lfs.2025.123822_bb0385","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1158\/0008-5472.CAN-14-3511","article-title":"TGFbeta is a master regulator of radiation therapy-induced antitumor immunity","volume":"75","author":"Vanpouille-Box","year":"2015","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.lfs.2025.123822_bb0390","article-title":"Co-targeting TGF-beta and PD-L1 with radiation therapy: the goldilocks principle","volume":"2","author":"Bakhoum","year":"2021","journal-title":"Cell Rep Med"},{"issue":"8","key":"10.1016\/j.lfs.2025.123822_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087614","article-title":"The role of TGF-beta3 in radiation response","volume":"24","author":"Hanson","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.123822_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1280741","article-title":"Targeting post-translational modifications of Foxp3: a new paradigm for regulatory T cell-specific therapy","volume":"14","author":"Riaz","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123822_bb0405","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.apcsb.2019.11.010","article-title":"Targeting FOXP3 complex ensemble in drug discovery","volume":"121","author":"Huang","year":"2020","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123822_bb0410","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003892","article-title":"Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer","volume":"10","author":"Revenko","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2025.123822_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42242","article-title":"Global research landscape and hotspots for ferroptosis in glioma: a comprehensive bibliometric and visual analysis","volume":"11","author":"Zheng","year":"2025","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.lfs.2025.123822_bb0420","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molmed.2021.06.014","article-title":"Ferroptosis in the tumor microenvironment: perspectives for immunotherapy","volume":"27","author":"Xu","year":"2021","journal-title":"Trends Mol. Med."},{"issue":"7","key":"10.1016\/j.lfs.2025.123822_bb0425","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/neuonc\/noac033","article-title":"Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance","volume":"24","author":"Liu","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.lfs.2025.123822_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102451","article-title":"TRIM7 modulates NCOA4-mediated ferritinophagy and ferroptosis in glioblastoma cells","volume":"56","author":"Li","year":"2022","journal-title":"Redox Biol."},{"issue":"31","key":"10.1016\/j.lfs.2025.123822_bb0435","doi-asserted-by":"crossref","first-page":"51164","DOI":"10.18632\/oncotarget.17737","article-title":"The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.lfs.2025.123822_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005251","article-title":"The regulatory T cell lineage factor Foxp3 regulates gene expression through several distinct mechanisms mostly independent of direct DNA binding","volume":"11","author":"Xie","year":"2015","journal-title":"PLoS Genet."},{"issue":"10","key":"10.1016\/j.lfs.2025.123822_bb0445","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ni.2402","article-title":"Transcription factor Foxp3 and its protein partners form a complex regulatory network","volume":"13","author":"Rudra","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2025.123822_bb0450","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2016.02.013","article-title":"Viral vectors for therapy of neurologic diseases","volume":"120","author":"Choudhury","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2025.123822_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.621831","article-title":"Current approaches for glioma gene therapy and virotherapy","volume":"14","author":"Banerjee","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.lfs.2025.123822_bb0460","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11910-024-01338-x","article-title":"Strategies to improve drug delivery across the blood-brain barrier for glioblastoma","volume":"24","author":"Narsinh","year":"2024","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"10","key":"10.1016\/j.lfs.2025.123822_bb0465","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1016\/j.ymthe.2023.08.009","article-title":"Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: translational developments from rodents to glioma patients","volume":"31","author":"Faisal","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2025.123822_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.634031","article-title":"Innovative and promising strategies to enhance effectiveness of immunotherapy for CNS tumors: where are we?","volume":"12","author":"Quintarelli","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123822_bb0475","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41423-021-00831-4","article-title":"Restoration of established systemic inflammation and autoimmunity by Foxp3(+) regulatory T cells","volume":"19","author":"Sharma","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2025.123822_bb0480","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","article-title":"Intratumoral oncolytic herpes virus G47\u2206 for residual or recurrent glioblastoma: a phase 2 trial","volume":"28","author":"Todo","year":"2022","journal-title":"Nat. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525004576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525004576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:12:26Z","timestamp":1777432346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525004576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":96,"alternative-id":["S0024320525004576"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123822","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting FOXP3 in glioblastoma: Blockade of tumor intrinsic effects boosts response to chemo-radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123822"}}